Here I share some of the latest news, articles, editorials, or blog posts that fall generally under the theme of Pharma or healthcare. I might throw in a something off-topic from time to time which I found while wandering throughout the endless hallways and corridors of the internet. All article shared will be free to read and not locked behind an annoying paywall.
AVERAGE PAY FOR PHARMACISTS BY STATE
Looks like California is leading the way at $151K, followed by Alaska at $146K. Otherwise, a bit surprising how close they all are, even in areas where cost of living is very different. Looks like West Virginia is at the bottom, at $119K. BECKERS. READ MORE.
BE A LESS-STRESSED LEADER
A helpful infographic from Advisory Board with tips for leaders on how to reduce stress and reduce your workload. “Stress is endemic in today’s health care workforce, but the good news is that leaders have much more control over their stress levels at work than they might think. The most effective leaders take steps to proactively keep their own stress in check—while modeling healthy habits for their teams.” ADVISORY BOARD. READ MORE.
OF THE TOP 50 BRAND DRUGS – HALF CITED AS LOW BENEFIT
“Of the 50 highest-selling brand-name drugs, 27 may provide low therapeutic benefit, according to a study of Medicare data from the Brigham and Women’s Hospital and Harvard Medical School. The study was published in JAMA.” DRUG TOPICS. READ MORE.
FDA-APPROVED FECAL TRANSPLANT IN A PILL
An easier-to-use oral alternative to fecal transplants for patients suffering from repeated C. diff has been approved by the FDA. “The treatment will be sold under the brand name Vowst and comes as a regimen of four daily capsules taken for three consecutive days…The FDA approved the treatment based on a 180-patient study in which nearly 88% of patients taking the capsules did not experience reinfection after 8 weeks, compared with 60% of those who received dummy pills.” NBC NEWS. READ MORE.
LYNPARZA-ABIRATERONE COMBO GETS NARROW NOD
A panel of experts voted 11-1 to support the use of AstraZeneca and Merck’s Lynparza with abiraterone and prednisone for patients with a confirmed BRCA mutation. “Pointing to what it viewed as a “modest” tumor progression benefit but a potential detriment to patient survival, the FDA argued that an approval for the Lynparza-Zytiga combo should be restricted to BRCA-mutant patients.” FIERCEPHARMA. READ MORE.
FOR FUN – A TREATISE ON IRRITATION
Having known people who seem to be chronically irritated at everything, this bit of writing and research on the topic I found to be entertaining and insightful. “Seemingly about every little thing and also nothing at all, irritation is a feeling in search of causes: it goes out into the world, and finds them.” AEON. READ MORE.
Last modified: May 4, 2023
